Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Breast Neoplasms × Nivolumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Melanoma 3 Carcinoma, Renal Cell 3 Various Advanced Cancer 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Stomach Neoplasms 1 Neoplasms 1 Microsatellite Unstable Colorectal Cancer 1 Mesothelioma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Advanced or Metastatic Solid Tumors 1 Advanced Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

Trastuzumab 6 Fulvestrant 6 abemaciclib 5 Capecitabine 5 trastuzumab deruxtecan 4 Paclitaxel 4 eribulin 3 Gemcitabine 3 Docetaxel 3 Cyclophosphamide 3 selpercatinib 2 sacituzumab govitecan 2 ribociclib 2 pertuzumab 2 olaparib 2 exemestane 2 Vinorelbine 2 Letrozole 2 Fluorouracil 2 Epirubicin 2 Doxorubicin 2 Anastrozole 2 Ado-Trastuzumab Emtansine 2 130-nm albumin-bound paclitaxel 2 tucatinib 1 talazoparib 1 palbociclib 1 neratinib 1 larotrectinib 1 inavolisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡